Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Qsymia
Qsymia
Vivus acquires patent rights to Qsymia ingredient
Yahoo/AP
Mon, 08/25/14 - 09:54 am
Vivus
patents
Qsymia
Janssen
JNJ
The Implications of Obesity as a Disability in Europe
Motley Fool
Sun, 07/20/14 - 09:10 am
obesity
weight loss
Arena Pharmaceuticals
Belviq
Orexigen
Vivus
Eisai
Qsymia
NB32
Vivus hits Actavis with Qsymia patent-infringement lawsuit
Fierce Pharma
Fri, 06/13/14 - 06:46 pm
patents
Vivus
Qsymia
Actavis
generics
Arena vs Vivus: Which Obesity Stock is a Buy? (video)
Motley Fool
Sat, 05/31/14 - 10:04 am
Arena Pharmaceuticals
Vivus
obesity
weight loss
Belviq
Qsymia
Orexigen's Weight Loss Drug Will Be Approved Soon And Will Lead Market - Here Is Why
Seeking Alpha
Wed, 05/28/14 - 09:45 am
obesity
Orexigen
FDA
Contrave
Vivus
Qsymia
Belviq
Arena Pharmaceuticals
The Future of Fat Fighting: Next-Gen Obesity Drugs
Motley Fool
Sun, 05/25/14 - 10:30 am
obesity
weight loss
Zafgen
beloranid
Arena
Vivus
Qsymia
Belviq
1 Obesity Drug Stock the Market Got Completely Wrong (video)
Motley Fool
Sun, 05/18/14 - 10:13 am
Vivus
Qsymia
weight loss
obesity
Vivus's diet pill faces generic threat from Actavis
Yahoo/Reuters
Fri, 05/9/14 - 10:34 am
Vivus
generics
obesity
Qsymia
Actavis
Will Arena Seize An Opportunity?
Seeking Alpha
Tue, 05/6/14 - 04:46 pm
Arena Pharmaceuticals
Vivus
Orexigen
Belviq
obesity
Qsymia
Vivus needs more than boardroom shuffling to keep up with Arena's Belviq
Fierce Pharma
Mon, 04/14/14 - 08:42 am
Belviq
Vivus
obesity
Arena Pharmaceuticals
Qsymia
Morning Movers in Biotech: Medicines Co., Omeros Corporation, Opko Health, Inc. and VIVUS, Inc.
Motley Fool
Thu, 04/3/14 - 09:21 am
Medicines Company
Omeros
OPKO Health
Vivus
OMS721
Qsymia
Fibrocaps
Arena - Scripts, Ads, Sales Reps
Seeking Alpha
Fri, 03/28/14 - 01:01 pm
Arena Pharmaceuticals
drug ads
drug reps
Belviq
Qsymia
Vivus
Vivus: Shares Are Oversold, Pressure Is On To Secure A Commercial Partner And Drive Market Penetration
Seeking Alpha
Wed, 03/26/14 - 04:58 pm
Vivus
Qsymia
Orexigen
Contrave
Belviq
Arena Pharmaceuticals
Vivus Announces Review Article Summarizing Cardiovascular Benefit-Risk Profile of Qsymia
Yahoo/Benzinga
Tue, 03/25/14 - 08:04 am
Vivus
Qsymia
Biotech Stock Roundup: InterMune Grabs Headlines with Impressive Data
Yahoo/Zacks.com
Wed, 03/5/14 - 11:46 am
InterMune
Esbriet
Alexion
Soliris
Vivus
Qsymia
Regeneron
Eylea
It's Always Darkest Before The Dawn: Why Vivus Could Double In Three Months And Triple In Twelve
Seeking Alpha
Mon, 03/3/14 - 11:51 am
Vivus
Qsymia
Stendra
Cheaper Obesity Drugs Available (for Half of Some Americans)
Daily Finance
Mon, 02/24/14 - 05:25 pm
obesity
Arena Pharmaceuticals
Eisai
Vivus
Orexigen
Belviq
Qsymia
Contrave
Biotech Showdown: Arena Pharmaceuticals vs. VIVUS Inc.
Motley Fool
Fri, 02/21/14 - 10:44 am
obesity
Arena Pharmaceuticals
Vivus
Belviq
Qsymia
Novo Nordisk
Orexigen
VIVUS collaborates with Aetna on Qsymia
Yahoo/Fly on the Wall
Tue, 01/14/14 - 08:19 am
Vivus
Aetna
Qsymia
Vivus Scores Insurance Win
Seeking Alpha
Thu, 01/2/14 - 12:38 pm
Vivus
Orexigen
obesity
insurance
Caremark
Arena Pharmaceuticals
Qsymia
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
next ›
last »